Introduction: The botulinum toxin is a valuable option for the treatment of dynamic facial wrinkles. The Lanzhou botulinum toxin type A (LBTX-A) was introduced in China in the early 90’s and approved in Brazil in 2003. Objective: Evaluate the efficacy and tolerability of LBTX-A for the cosmetic treatment of dynamic wrinkles of the upper face. Material and Methods: In a prospective, open-label, multicenter study, 110 subjects of both sexes (aged from 25 to 65 years) were treated with a total of 53 U of LBTX-A each, distributed in fi fteen sites in the frontal, corrugator, procerus, orbicular ocular lateral muscles. The patients were reviewed 7 times within 180 days. Efficacy was assessed by electromyography, photographic analysis and the investigator’s and patient’s opinions. Tolerability was assessed by the incidence of adverse events.Results: Two weeks post-injection, 94% of the treated patients considered the result as good or excellent. Results lasted 90 days in most cases. After injection, most patients reported mild or no pain, and minimal and reversible side effects as facial edema (6 patients), stuffiness feeling (3 patients) and eyelid ptosis (2 patients). Conclusions: We conclude that LBTX-A is effi cient and well tolerated for the treatment of dynamic facial lines.

Keywords: BOTULINUM TOXIN TYPE A, INJECTABLES, WRINKLES, FACIAL DYNAMIC LINES

Structural alterations resulting from the aging process of the face are related to muscular action, skin sagging, loss of bone support, and decrease in the volume of facial fat compartments-all inducing alterations in facial contour over the years. The authors have carried out a review of the main causes linked to the so-called facial contour alteration in aging and defined a new denomination for this process: "facial squaring", the process through which the shape of the face-which is that of an inverted trapezoid in youth-becomes that of a square over time.

Keywords: REJUVENATION; SKIN; FACIAL MUSCLES.

Introduction: Facial paralysis triggers asymmetries and other functional and aesthetic facial changes, which lead to significant physical and psychological disorders. Botulinum toxin type A is a safe, effective, and well-tolerated therapy, making it a good option for treating those conditions. Objective: To demonstrate the clinical improvement and the degree of satisfaction among patients bearing facial asymmetries and dyskinesias, who have been treated with botulinum toxin type A injections performed by dermatologists. Methods: Patients with facial asymmetries and dyskinesias were selected between January 2011 and December 2013, to receive botulinum toxin injections aimed at reducing muscle activity on the normal side of the face (in cases of facial hemiparesis) or directly into the affected muscles in cases of dyskinesias. The clinical evaluations and photographic records in static and dynamic positions were carried out on the days of the first application (D0) and fifteen days after (D15). Each patient was rescheduled for a future session within120 days. Results: There was clinical improvement with reduction of asymmetries and dyskinesias verified at the beginning of treatment following application of the toxin. A significant improvement in the patients' quality of life, with a positive impact in different areas of their personal lives, could be noticed. Conclusions: Treatment with botulinum toxin type A, performed by dermatologists with previous experience in the management of this procedure in other conditions, proved to be an important alternative in the treatment of asymmetries and facial dyskinesias.

Keywords: FACIAL ASYMMETRY; FACIAL PARALYSIS; QUALITY OF LIFE; BOTULINUM TOXINS, TYPE A.

Introduction: Currently there is a growing demand for non-invasive therapies aimed at treating facial aging. Non-ablative fractional lasers lead to excellent outcomes, with reduced side effects. Objective: To evaluate the facial rejuvenation achieved by 1,340nm non-ablative fractional laser using a single pass at high energy versus three passes at medium energy, through a prospective comparative study. Methods: Twenty patients with facial aging were treated with 2 or 3 laser sessions with 4-week intervals. The right hemiface was treated with three passes of 1,340nm non-ablative fractional laser at a fluence of 90 mJ, pulse duration of 5ms and 100 mtz/ cm2. The left hemiface was treated with a single pass of the same laser at a fluence of 120 mJ, pulse duration of 5ms and 100 mtz/cm2. The evaluated variables were spots, wrinkles, porphyrins and overall appearance. Results: The patients (n = 20) were evaluated during 6 to 24 months. The photographic evaluations demonstrated a significant improvement of the spots on the right hand side and wrinkles on the right and left hand sides. Eighteen of the 20 patients reported satisfaction with the treatment. Conclusion: 1,340nm non-ablative fractional laser was proven as a modern, safe and effective alternative for facial rejuvenation. For spots, the triple passes at medium energy protocol led to a superior response. However, regarding wrinkles there was no difference between the single pass at high energy and triple pass at medium energy protocols.

Keywords: LASER; REJUVENATION; FACIAL AGING; FACE

The association of cysts and comedones in chronically sun-damaged skin characterizes the Favre-Racouchot syndrome. The authors report a case of a 64 year-old male patient with a history of smoking and tillage work activity. The patient had lesions in the malar, zygomatic and mandibular regions bilaterally, constituted by slightly erythematous cysts and large comedones in thickened skin with deep grooves. The condition was diagnosed as Favre-Racouchot syndrome, and treated by means of surgical excision. The objective of the present study is to describe an exuberant presentation of the syndrome, and its treatment via surgical excision.

Keywords: Facial dermatoses; Photosensitivity disorders; Skin aging

Facial hemiatrophy, or Parry-Romberg syndrome, is characterized by the progressive atrophy of the tissues of half of the face, affecting skin and subcutaneous tissue. Its clinical manifestations are very varied. Preferred therapeutic strategies for the treatment of the syndrome were not yet completely established. The authors describe a case of mild facial hemiatrophy, in which the patient underwent lipofilling (autologous fat grafting), progressing with satisfactory result. Treatment alternatives, its advantages and disadvantages are widely discussed in the study, with fat grafting emerging as an excellent therapeutic option due to its safety, low cost and replicability.

Keywords: Face; Facial hemiatrophy; Transplantation, autologous

Brooke-Spiegler syndrome is a rare autosomal dominant genetic disease with predisposition to many adnexal tumors, including trichoepithelioma, cylindroma and spiroadenoma. Tumors appear in the second decade of life, progressively increase with age, and their prevalence is higher in women. It is caused by a mutation in the CYLD gene, localized in the chromosome 16q12-q13. We report a exuberant case of giant eccrine spiradenoma associated to this syndrome.

Keywords: Dermatologic Surgical Procedures; Facial Neoplasms; Neoplasms, Adnexal and Skin Appendage

The application of botulinum toxin to patients with sequelae of Bell's palsy is a beneficial adjuvant therapy for the reduction of synkinesia and facial asymmetries. Bell's palsy is the most common cause of facial nerve paralysis.After the paralysis phase of the facial muscles, the condition may evolve with facial asymmetry and synkinesia. In the treatment of synkinesia, punctual injections into the orbicularis and platysma muscles relieve the spasms. Selective application to the unaffected hemiface aims to reduce facial asymmetry and its negative social impact, with improved quality of life.

Keywords: Facial paralysis; Bell palsy; Botulinum toxins, type A; Rehabilitation; Quality of life

Nodular fasciitis is a benign tumor resulting from the reactive proliferation of fibroblastic or myofibroblastic cells presenting rapid growth and rich cellularity. In adults, the extremities’ involvement is more frequent; however, other regions can be affected. In this report, we present the case of a 40-year-old woman with a nodular lesion on the forehead. The histopathology confirmed the diagnosis of nodular fasciitis. The reported case highlights its rare location and alerts the clinical dermatologist in its inclusion among the differential diagnoses of tumor lesions on the face.

Keywords: Facial Dermatoses; Fasciitis; Forehead

INTRODUCTION: The use of botulinum toxin has become one the essential cosmetic procedures performed in the world.
OBJECTIVE: To identify patterns of muscle contraction of the forehead, glabellar complex, and orbicularis oculi muscle in patients from southern Brazil, establishing their epidemiology and possible associations between them.
METHODS: One hundred and one patients who sought treatment with botulinum toxin for the forehead, glabella, and periocular lines between 2012 and 2016 were included. Analyzes were made using digital photographs taken during a medical consultation before applying the products., The subjects received with different brands of botulinum toxin, according to the patients’ or the doctors’ preference
RESULTS: The most common contraction patterns were complete frontal, glabellar in converging arrows, and complete periocular. Women represented 94.1% of patients. Most patients were between 31 and 50 years old, with an average of 44.57 years. More frequent patterns in each area were more frequently associated.
CONCLUSIONS: The study shows the main muscle contraction patterns of the upper third of the face in 101 patients, as well as their clinical characteristics, comparing them with previously published articles. Studies on muscle contraction patterns can assist in the safer and more rational use of the products available, avoiding waste and complications.

Keywords: Muscle contraction; Skin aging; Face; Facial muscles; Botulinum toxins type A

INTRODUCTION: Progressive Facial Hemiatrophy, also known as Parry Romberg Syndrome, is a rare form of linear scleroderma. The management of facial atrophy sequelae is challenging.
OBJECTIVE: This study aims to evaluate for the first time in literature the effectiveness of the calcium hydroxylapatite (CaHa) filler in the jawline reshaping of a patient with Parry Romberg Syndrome.
CASE REPORT: A 15-year-old woman with progressive atrophy of the right side of the face due to Parry Romberg Syndrome. After disease control, the patient’s main complaint was facial asymmetry, mainly in the jawline region.
DISCUSSION: CaHa is a biocompatible injectable filler that is gradually resorbed and replaced by fibrovascular stroma, mainly formed for new collagen, in a process that occurs without any immunological reaction. This safety profile makes CaHa a good choice for correcting stable scleroderma defects.
CONCLUSION: This report concludes that CaHa filler biocompatibility and suitability for the jawline correction are also applicable in reconstructive procedures for stable scleroderma, safely and minimally invasively, with optimal aesthetic results. The method must be programmed case-by-case, and a regular follow-up is also recommended.

Keywords: Scleroderma localized; Facial hemiatrophy; Dermal fillers

Localized scleroderma (linear morphea) is a rare disease that causes facial dystrophy and asymmetry in young women. We report the case of a 20-year-old female patient who was treated with novel composite fat grafts. After extracting lipoaspirate from deep subcutaneous fat, the microfat and the unfiltered nanofat were processed separately, and amalgamated, obtaining composite fat grafts. These were meticulously transplanted layer by layer to rebuild the subcutaneous tissue of the patient's face. After one year, a good volume of fat retention was observed with successful correction of asymmetry and restoration of facial balance.

Keywords: Ambulatory surgical procedures; Abdominal subcutaneous fat; Facial asymmetry; Subcutaneous injections; Localized scleroderma

Autologous fat grafting is a common option for the correction of facial asymmetry. Recently, therapies using injectable substances that promote lipolysis have emerged to reduce undesired fat volume, offering an alternative to surgical removal of adipose tissue. We report an experimental case in which fat-dissolving injections were used to correct facial asymmetry following fat grafting, demonstrating satisfactory results with a minimally invasive procedure.

Keywords: Facial Asymmetry; Adipose Tissue, Subcutaneous; Mesotherapy.

INTRODUCTION: Parry-Romberg syndrome and linear scleroderma en coup de sabre are disorders within the scleroderma spectrum, a disease that presents therapeutic challenges.
OBJECTIVES: We treated three patients with this condition using poly-L-lactic acid (PLLA) with the aim of alleviating facial asymmetries and evaluated the real improvement of scleroderma lesions with high-resolution ultrasound.
METHODS: The patients underwent two to four sessions of biostimulation with PLLA over a 12-month period.
RESULTS: The results were promising, demonstrating favorable cosmetic outcomes with increased thickness of the dermis and hypodermis as evidenced by high-resolution ultrasound.
CONCLUSIONS: Biostimulation with PLLA is a safe and effective treatment option for these patients when administered by trained professionals.

Keywords: Facial Hemiatrophy; Scleroderma, Localized; Dermal Fillers; Ultrasonography.

BACKGROUND: Reconstructive surgery remains the primary approach for treating facial skin cancer, aiming to restore both anatomy and aesthetics. Local flaps are commonly preferred for facial reconstruction.
OBJECTIVE: To describe the clinical and subclinical characteristics of facial skin cancer and evaluate treatment outcomes using local flaps.
METHODS: A descriptive cross-sectional study with clinical intervention, without a control group, was conducted on 84 patients diagnosed with facial skin cancer and treated at Can Tho City Oncology Hospital from May 2021 to April 2023.
RESULTS: Outcomes were assessed during hospitalization and 6 months postoperatively. Among the 84 patients, 68 had basal cell carcinoma, and 16 had squamous cell carcinoma. The nose was the most frequently treated site, accounting for 43 cases. Lesions smaller than 2 cm comprised 70.2% of cases. After 6 months, 65 out of 84 flap sites (77.4%) exhibited minimal scarring that could be concealed, with an aesthetic success rate of 73.8%.
CONCLUSIONS: Key factors influencing surgical outcomes include the surgeon's experience, lesion location and size, tumor invasion extent, and skin elasticity.

Keywords: Facial Dermatoses; Surgical Flaps; Southeast Asian People.